Accenture plc (ACN) concluded trading on Thursday at a closing price of $281.71, with 3.95 million shares of worth about $1.11 billion changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -21.55% during that period and on July 24, 2025 the price saw a loss of about -1.51%. Currently the company’s common shares owned by public are about 622.75M shares, out of which, 621.21M shares are available for trading.
Stock saw a price change of -0.35% in past 5 days and over the past one month there was a price change of -6.32%. Year-to-date (YTD), ACN shares are showing a performance of -15.02% which decreased to -19.92% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $273.19 but also hit the highest price of $398.35 during that period. The average intraday trading volume for Accenture plc shares is 3.28 million. The stock is currently trading -3.01% below its 20-day simple moving average (SMA20), while that difference is down -7.42% for SMA50 and it goes to -15.86% lower than SMA200.
Accenture plc (NYSE: ACN) currently have 622.75M outstanding shares and institutions hold larger chunk of about 78.74% of that.
The stock has a current market capitalization of $175.46B and its 3Y-monthly beta is at 1.29. PE ratio of stock for trailing 12 months is 22.42, while it has posted earnings per share of $12.56 in the same period. Its PEG reads 2.91 and has Quick Ratio of 1.46 while making debt-to-equity ratio of 0.27. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ACN, volatility over the week remained 1.50% while standing at 1.79% over the month.
Stock’s fiscal year EPS is expected to rise by 7.72% while it is estimated to increase by 7.18% in next year. EPS is likely to shrink at an annualized rate of 7.70% for next 5-years, compared to annual growth of 9.21% made by the stock over the past 5-years.
Coverage by Evercore ISI stated Accenture plc (ACN) stock as an Outperform in their note to investors on July 17, 2025, suggesting a price target of $330 for the stock. On March 17, 2025, Robert W. Baird Upgrade their recommendations, while on January 08, 2025, Wolfe Research Upgrade their ratings for the stock with a price target of $425. Stock get a Buy rating from Goldman on December 06, 2024.
